EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Transglutaminase‐mediated cytokeratin modifications implicated in bile‐acid‐induced hepatocyte death

Hideki Tatsukawa iD, Haruka Nakagawa, Chin Mun Yee, Keiko Kuwata, Kiyotaka Hitomi iD

The FEBS Journal · 2026

DOI: 10.1111/febs.70281 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FEBS Journal, 2026. Verfasst von Hideki Tatsukawa und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cellular Biochemistry Lab., Graduate School of Pharmaceutical Sciences, Tokai National Higher Education and Research System, Nagoya University, Japan. Hauptthemen laut MEDLINE: Hepatocytes, Transglutaminases, Keratin-18, Keratin-8. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Takeda Science Foundation, Daiko Foundation, Tokyo Biochemical Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transglutaminases (TGs) are crosslinking enzymes that catalyze the formation of isopeptide bonds between glutamine and lysine residues. They consist of eight isozymes: TG1–TG7 and factor XIIIa. Our previous studies have shown that TG1 and TG2 facilitate hepatic apoptosis, contributing to liver fibrosis, and that their crosslinking substrates—cytokeratin 18 (K18) and cytokeratin 8 (K8)—are also targeted by TGs in a bile‐duct‐ligation‐induced mouse model of liver fibrosis. However, the precise mechanisms by which TGs and keratins contribute to hepatocyte damage remain unclear. This study investigates the molecular mechanisms underlying TG1‐ and TG2‐mediated cell death in hepatocytes exposed to bile acids. HepG2 cells and primary hepatocytes were treated with glycochenodeoxycholic acid (GCDCA), a toxic bile salt elevated in cholestasis. GCDCA‐reduced cell viability and induced apoptosis in a dose‐dependent manner. Knockdown of K18/K8 or TG1/TG2 by siRNA significantly attenuated GCDCA‐induced apoptosis, indicating their contributory roles in hepatocyte injury. GCDCA‐treated cells showed increased levels of proteins crosslinked by TG1 and TG2. In vivo analysis using cholestatic model mice also showed elevated high‐molecular‐weight protein complexes involving K18/K8, suggesting early‐stage Mallory body formation, as observed in chronic liver injury. Mass spectrometry identified cytoskeletal proteins, such as vimentin and periplakin, and regulatory proteins, such as ATP synthase subunit β and PI3K adapter protein, as K18‐crosslinked partners. These results suggest that TG1/TG2‐mediated aggregation of K18 sequesters essential structural and survival proteins, promoting hepatocyte apoptosis. Targeting these pathological interactions may provide a novel therapeutic strategy to mitigate liver fibrosis and improve hepatocyte survival.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HepatocytesTransglutaminasesKeratin-18Keratin-8GTP-Binding ProteinsBile Acids and SaltsHumansAnimalsApoptosisProtein Glutamine gamma Glutamyltransferase 2MiceHep G2 CellsGlycochenodeoxycholic AcidCell Survival

Stichwörter der Autor:innen

bile‐acidcholestasisfibrosisliver injurytransglutaminase

Substanzen

TransglutaminasesKeratin-18Protein Glutamine gamma Glutamyltransferase 2Keratin-8GTP-Binding ProteinsGlycochenodeoxycholic Acidtransglutaminase 1Bile Acids and Salts

Autor:innen und Institutionen

  • Cellular Biochemistry Lab., Graduate School of Pharmaceutical Sciences, Tokai National Higher Education and Research System, Nagoya University, Japan.
  • Institute of Transformative Bio-Molecules (ITbM), Tokai National Higher Education and Research System, Nagoya University, Japan.

ORCID-Profile: Hideki Tatsukawa, Kiyotaka Hitomi

Förderung

  • Takeda Science Foundation
  • Daiko Foundation
  • Tokyo Biochemical Research Foundation
  • Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan
  • Precursory Research for Embryonic Science and Technology
  • Japan Foundation for Applied Enzymology
  • Japan Society for the Promotion of Science

Zitieren

APA

Tatsukawa, H., Nakagawa, H., Yee, C. M., Kuwata, K., & Hitomi, K. (2026). Transglutaminase‐mediated cytokeratin modifications implicated in bile‐acid‐induced hepatocyte death. The FEBS Journal. https://doi.org/10.1111/febs.70281

Vancouver

Tatsukawa H, Nakagawa H, Yee CM, Kuwata K, Hitomi K. Transglutaminase‐mediated cytokeratin modifications implicated in bile‐acid‐induced hepatocyte death. The FEBS Journal. 2026. doi:10.1111/febs.70281

BibTeX
@article{Tatsukawa2026,
  author = {Tatsukawa, Hideki and Nakagawa, Haruka and Yee, Chin Mun and Kuwata, Keiko and Hitomi, Kiyotaka},
  title = {Transglutaminase‐mediated cytokeratin modifications implicated in bile‐acid‐induced hepatocyte death},
  journal = {The FEBS Journal},
  year = {2026},
  doi = {10.1111/febs.70281}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche